BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8827074)

  • 21. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.
    Liu J; Nau MM; Yeh JC; Allegra CJ; Chu E; Wright JJ
    Clin Cancer Res; 2000 Sep; 6(9):3522-9. PubMed ID: 10999739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hox11 is required to maintain normal Wt1 mRNA levels in the developing spleen.
    Koehler K; Franz T; Dear TN
    Dev Dyn; 2000 May; 218(1):201-6. PubMed ID: 10822272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WT1-mediated gene regulation in early urogenital ridge development.
    Klattig J; Sierig R; Kruspe D; Makki MS; Englert C
    Sex Dev; 2007; 1(4):238-54. PubMed ID: 18391535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells.
    Scharnhorst V; Kranenburg O; van der Eb AJ; Jochemsen AG
    Cell Growth Differ; 1997 Feb; 8(2):133-43. PubMed ID: 9040935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.
    Mrowka C; Schedl A
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S106-15. PubMed ID: 11065340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential regulation of the human Wilms tumour suppressor gene (WT1) promoter by two isoforms of PAX2.
    McConnell MJ; Cunliffe HE; Chua LJ; Ward TA; Eccles MR
    Oncogene; 1997 Jun; 14(22):2689-700. PubMed ID: 9178767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of p21 by the Wilms' tumor suppressor gene WT1.
    Englert C; Maheswaran S; Garvin AJ; Kreidberg J; Haber DA
    Cancer Res; 1997 Apr; 57(8):1429-34. PubMed ID: 9108440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The desmoplastic small round cell tumor t(11;22) translocation produces EWS/WT1 isoforms with differing oncogenic properties.
    Kim J; Lee K; Pelletier J
    Oncogene; 1998 Apr; 16(15):1973-9. PubMed ID: 9591781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coordinate action of Wt1 and a modifier gene supports embryonic survival in the oviduct.
    Kreidberg JA; Natoli TA; McGinnis L; Donovan M; Biggers JD; Amstutz A
    Mol Reprod Dev; 1999 Apr; 52(4):366-75. PubMed ID: 10092116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
    Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence of the WT1 upstream region including the Wit-1 gene.
    Gessler M; Bruns GA
    Genomics; 1993 Aug; 17(2):499-501. PubMed ID: 8406502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the wt1 Wilms' tumor suppressor gene by NF-kappaB.
    Dehbi M; Hiscott J; Pelletier J
    Oncogene; 1998 Apr; 16(16):2033-9. PubMed ID: 9572484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S; Royer-Pokora B
    Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1).
    Adachi Y; Matsubara S; Pedraza C; Ozawa M; Tsutsui J; Takamatsu H; Noguchi H; Akiyama T; Muramatsu T
    Oncogene; 1996 Nov; 13(10):2197-203. PubMed ID: 8950987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wilms' tumor suppressor gene (WT1) as a target gene of SRY function in a mouse ES cell line transfected with SRY.
    Toyooka Y; Tanaka SS; Hirota O; Tanaka S; Takagi N; Yamanouchi K; Tojo H; Tachi C
    Int J Dev Biol; 1998 Nov; 42(8):1143-51. PubMed ID: 9879712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2.
    Discenza MT; He S; Lee TH; Chu LL; Bolon B; Goodyer P; Eccles M; Pelletier J
    Oncogene; 2003 Nov; 22(50):8145-55. PubMed ID: 14603255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
    Morrison AA; Viney RL; Saleem MA; Ladomery MR
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C; McGee SB; Cornwell MM
    Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The third zinc finger of the WT1 gene is mutated in Wilms' tumour but not in a broad range of other urogenital tumours.
    Quek HH; Chow VT; Tock EP
    Anticancer Res; 1993; 13(5A):1575-80. PubMed ID: 8239537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.